AMO v. Alcon (D. Del. & PTAB): Represented Alcon in patent and copyright case related to Alcon’s LenSx cataract surgery device in district court, PTAB, and foreign jurisdictions. Won summary judgment significantly reducing potential exposure. Oversaw drafting of 16 IPR petitions against AMO patents and successfully argued at PTAB in defense of Alcon patent. Case favorably settled on eve of trial.
Janssen v. Celltrion (D. Mass.): Represented Hospira and Celltrion in litigation in federal district court and the Federal Circuit related to biosimilar version of Janssen’s multi-billion-dollar drug Remicade®. The case involved the first biosimilar monoclonal antibody to be approved by the FDA, and is one of the first cases filed under the Biologics Price Competition and Innovation Act (BPCIA). Obtained summary judgment in client’s favor which was affirmed on appeal.
Abbott v. Grifols (N.D. Ill.): Represented Abbott in declaratory judgment action seeking to invalidate Grifols’ patent related to replication of HIV. Won summary judgment significantly reducing potential exposure. Case favorably settled in advance of trial.
Arkema v. Honeywell (PTAB & Fed. Cir.); Mexichem v. Honeywell (PTAB): Represented Honeywell in Post-Grant Review and inter-partes reexaminations of patents related to next generation automobile refrigerants. Successfully obtained two separate Federal Circuit decisions vacating and remanding case after PTAB had found patents invalid.
Samsung Bioepis v. Janssen (PTAB): Drafted IPR petition against patent related to Janssen’s STELARA® biologic. Case favorably settled shortly after filing IPR petition.
SherryWear v. Nike (D. Mass. & PTAB): Representing Nike in defense of patent infringement suit related to sports bras with pockets. Argued Markman, after which court found in favor of Nike on all disputed claim terms. After filing IPR petitions against all asserted patents successfully moved district court to stay proceeding pending PTAB decision.
